These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 2405384

  • 1. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction.
    Sawyers CL, Timson L, Kawasaki ES, Clark SS, Witte ON, Champlin R.
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):563-7. PubMed ID: 2405384
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.
    Delage R, Soiffer RJ, Dear K, Ritz J.
    Blood; 1991 Nov 15; 78(10):2759-67. PubMed ID: 1824268
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia.
    Roth MS, Antin JH, Ash R, Terry VH, Gotlieb M, Silver SM, Ginsburg D.
    Blood; 1992 Jan 01; 79(1):276-82. PubMed ID: 1728316
    [Abstract] [Full Text] [Related]

  • 5. Estimations of BCR-ABL/ABL transcripts by quantitative PCR in chronic myeloid leukaemia after allogeneic bone marrow transplantation and donor lymphocyte infusion.
    Otazú IB, Tavares Rde C, Hassan R, Zalcberg I, Tabak DG, Seuánez HN.
    Leuk Res; 2002 Feb 01; 26(2):129-41. PubMed ID: 11755463
    [Abstract] [Full Text] [Related]

  • 6. Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation.
    Lee M, Khouri I, Champlin R, Kantarjian H, Talpaz M, Trujillo J, Freireich E, Deisseroth A, Stass S.
    Br J Haematol; 1992 Dec 01; 82(4):708-14. PubMed ID: 1482658
    [Abstract] [Full Text] [Related]

  • 7. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation.
    Cross NC, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM.
    Blood; 1993 Sep 15; 82(6):1929-36. PubMed ID: 8400243
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation.
    Lin F, van Rhee F, Goldman JM, Cross NC.
    Blood; 1996 May 15; 87(10):4473-8. PubMed ID: 8639810
    [Abstract] [Full Text] [Related]

  • 10. bcr/abl mRNA detection following bone marrow transplantation for chronic myelogenous leukemia.
    Ely P, Miller WJ.
    Transplantation; 1991 Dec 15; 52(6):1023-8. PubMed ID: 1750065
    [Abstract] [Full Text] [Related]

  • 11. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse.
    Serrano J, Roman J, Sanchez J, Jimenez A, Castillejo JA, Herrera C, Gonzalez MG, Reina L, Rodriguez MC, Alvarez MA, Maldonado J, Torres A.
    Blood; 2000 Apr 15; 95(8):2659-65. PubMed ID: 10753848
    [Abstract] [Full Text] [Related]

  • 12. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
    Zhang JG, Lin F, Chase A, Goldman JM, Cross NC.
    Blood; 1996 Mar 15; 87(6):2588-93. PubMed ID: 8630427
    [Abstract] [Full Text] [Related]

  • 13. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT).
    Gaiger A, Lion T, Kalhs P, Mitterbauer G, Henn T, Haas O, Födinger M, Kier P, Forstinger C, Quehenberger P.
    Leukemia; 1993 Nov 15; 7(11):1766-72. PubMed ID: 8231244
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J, Serrano J, Jiménez A, Castillejo JA, Reina ML, González MG, Rodríguez MC, García I, Sánchez J, Maldonado J, Torres A.
    Haematologica; 2000 Feb 15; 85(2):173-80. PubMed ID: 10681725
    [Abstract] [Full Text] [Related]

  • 19. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.
    Lion T, Gaiger A, Henn T, Hörth E, Haas OA, Geissler K, Gadner H.
    Leukemia; 1995 Aug 15; 9(8):1353-60. PubMed ID: 7643624
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.